Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03332667
Title MIBG With Dinutuximab +/- Vorinostat
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors New Approaches to Neuroblastoma Therapy Consortium
Indications

ganglioneuroblastoma

neuroblastoma

Therapies

131I-MIBG + Dinutuximab + Sargramostim + Vorinostat

131I-MIBG + Dinutuximab + Sargramostim

Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Recruiting Los Angeles California 90027-0700 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco California 94143 United States Details
Children Hospital of Colorado Recruiting Aurora Colorado 80045 United States Details
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Recruiting Atlanta Georgia 30322 United States Details
University of Chicago, Comer Children's Hospital Recruiting Chicago Illinois 60637 United States Details
Children's Hospital Boston Recruiting Boston Massachusetts 02115 United States Details
C.S Mott Children's Hospital Recruiting Ann Arbor Michigan 48109 United States Details
University of North Carolina Active, not recruiting Chapel Hill North Carolina 27599 United States Details
Cincinnati Children's Hospital Medical Center Recruiting Cincinnati Ohio 45229-3039 United States Details
Children's Hospital of Philadelphia Recruiting Philadelphia Pennsylvania 19104-4318 United States Details
Cook Children's Healthcare System Recruiting Fort Worth Texas 76104 United States Details
Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle Washington 98105 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field